DatasetName,ENAH_S(125) ENAH_S(136) ENAH_S(414) ENAH_S(477) ENAH_S(485) ENAH_S(486) ENAH_S(508) ENAH_S(516) ENAH_S(528) ENAH_S(531) ENAH_S(537) ENAH_S(544) ENAH_S(718) ENAH_T(464) ENAH_T(483) ENAH_T(489) ENAH_T(502),ENAH_S(488) ENAH_S(717) ENAH_S(9) ENAH_T(3) ENAH_T(6),ENAH_S(171) ENAH_S(463) ENAH_S(506) ENAH_S(527) ENAH_S(709) ENAH_T(125) ENAH_T(538) ENAH_T(696) ENAH_T(721)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,,,
FSO2013_Ratio M/L normalized Rep3,0.4998569251436173,,
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),0.48797333897539813,,0.6053129103428346
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,0.49519506240643285,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,0.486510042231095,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,0.5002997663697449,,
RKK2015_TNF-α/basal,0.49276936536549376,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,0.48127380005148185,,
HS2024_6_B_T3,0.4971183907477278,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,0.5097626126516582,,
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,0.5010063789016336,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,,,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,0.49247047934630167,,
AST2020_anti-CD3.2,,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,0.5133978534575218,,
FSO2013_Ratio M/L normalized Rep1___1,0.49909696953851335,,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,,,
RB2022_5_PreEndurance,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,0.5096220733694968,,0.6098394227571379
WZ2023_Pu_010_30min,0.458357469940091,,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,0.49351303782721,,
RB2022_8_RecoveryEndurance,,,0.643043676156181
KBE2022_Log2_Ex_14_U,,,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,0.5099457746364815,,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,,,
RB2022_5_PreSprint,,,0.6170478044277663
PG2020_Intensity 8h_C,0.47695715643571407,,
AH2018_SILAC_MR_2_N,0.4785568081109381,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,0.49290773323968506,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,,,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,0.4966223777788939,,
FSO2013_Ratio H/L normalized Rep2___2,0.4824266801625621,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5035484122009263,,0.6148635363597822
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,0.4924059521442276,,
RB2022_5_PostStrength,,,0.6471263184276975
GF2025_P6_Sph,0.48461707849210783,,
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,0.4808651824027956,,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.46954951869501393,,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,,,
KBE2022_Log2_Ex_34_U,,,
WZ2023_Pu_005_10min,0.47397979331484474,,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,0.47830788644480754,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.45492072727855165,,
AH2018_SILAC_MR_2_X,0.49056136560177294,,
HS2024_4_PD_T2,0.4547250867705273,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,,,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,,,
EJN2021_3_Rest_Basal,,,0.6119088938770565
CR2017_Ratio Replicate 1.3,,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,,,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,0.4883223192352375,,
HS2024_7_PD_T2,0.5070952603047211,,0.6383153104125466
FSO2013_Ratio H/L normalized Rep1___1,0.49734423924080545,,
AH2018_LFQ_1_C,0.4912726735447787,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,,,
HS2024_3_B_N1,0.4446255767636948,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.46635121499458043,,
CK2022_11 40-1,0.4774309554613609,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,0.4875602449343256,,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,0.4887452030203062,,
FSO2013_Ratio H/L normalized Rep2,0.5041813299091095,,
WZ2023_Pu_005_20min,0.45808680483751557,,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,0.5065569076966173,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,0.4942999398707373,,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,0.497464330202149,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,0.4467538851857566,,0.603978047558399
FSO2013_Ratio M/L normalized Rep3___2,0.49675185328387694,,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,0.48265419197670384,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,0.45565001862762133,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,0.48136316273717095,,
CK2022_1 200-1,0.48013818539517494,,
PG2020_Intensity Mock_10h_D,0.4886632232815946,,
SR2019_MCF10A_Biol_repl_2,,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,0.5406265218387293,,0.6311052381602281
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,0.4743288477595463,,0.6387089294668641
RCJD2014_5min_1,0.4933751382939048,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,0.493172155959997,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,0.4866680386913824,,
PG2020_Intensity 2h_C,0.46866624056963446,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,0.47970700158801804,,
KBE2022_Log2_Ex_8_T,,,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,0.541622049803065,,0.6331756375444463
RN2012_L11,0.4806487491476381,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,0.47681137513689625,,
AH2018_LFQ_M_2_C,0.490704443765562,,
CK2022_3 40-1,0.4856107425640673,,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,0.46493815000880484,,
YA2020_Reporter_intensity_Cancer_No.5,0.486242472390962,,
HH2022_Reporter intensity 8,,,0.6104484184982615
ZQ2022_N2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,0.4846680554990807,,
EJN2021_5_Rest_Basal,,,0.6131316384571809
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,0.48834870704686895,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,,,
YA2020_Reporter_intensity_Normal_No.1,0.4871054974130512,,
HS2024_3_B_T1,0.47902421073796236,,0.6134102149752525
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,,
RB2022_1_PostEndurance,,,
CR2017_Ratio Replicate 3,,,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,,,0.6466098826240106
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,0.4835882884556688,,
HS2024_8_I_T3,0.4990365766335978,,
CF2017_EOC 3,,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,0.5140113600688081,,0.6229068749333108
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.46201313917640763,,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,0.48608042780148136,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,0.4879411892991855,,
KS2014_Intensity N3,0.4612630460793599,,
RB2022_4_RecoveryEndurance,,,
RB2022_5_RecoveryEndurance,,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,0.500014681657344,,
FSO2013_Ratio H/M normalized Rep2,0.4871737085073169,,
RAM2015_Log2 A,0.4811333241706759,,0.6097335051646265
HS2024_8_PD_T1,0.5038546596693206,,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,,,
KS2014_Intensity E15_2,0.4905171933020963,,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,0.4723604405883934,,
HS2024_7_I_T1,0.49409820700600365,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,0.48776799751322647,,0.6101634644548128
SR2019_JIMT1_Biol_repl_1,,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,0.4461271096900337,,
AH2018_SILAC_M_3_X,,,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,,,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,0.4773790199635567,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,0.5098567320012508,,0.6099799425984714
HS2024_6_B_N1,0.5108513724528178,,
KBE2022_Log2_Ex_27_T,,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.3431775371625738,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,,,
AH2018_SILAC_IT_3_X,0.49210643269254106,,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,0.485521865466683,,
FSO2013_Ratio M/L normalized Rep2,0.5152751206801277,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,0.48810825811363306,,0.6145025697852018
SR2019_HCC1954_Biol_repl_2,,,
CK2022_14 40-1,0.4795551897792561,,
RB2022_6_PreSprint,,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,0.4599936617177952,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,0.4832404736652291,,
DL2023_control-1,,,
AR2021_ALG 10 μM,0.48755982377351864,,0.6268888315443354
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,0.4924559319162353,,
EJN2021_4_Rest_Ins,,,0.6152127204950762
RN2012_H05,0.49820977025415386,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,0.48409752089565666,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,,,
EJN2021_1_Rest_Ins,,,0.6140537498190181
HH2022_Reporter intensity 3,0.48453038323756903,,0.6199913001575352
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,0.5014074304690384,,
JW2021_After_3,,,
GF2025_P8_Sph,0.47854202382591365,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,0.48803145182627694,,
CK2022_11 200-1,0.45526121038920586,,
CK2022_12 200-1,0.4543285040367061,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,0.4866002718895889,,0.6319901425327635
WZ2023_Su_010_20min,0.46298718406170614,,
AH2018_TMTMS2_2_N,0.5111928257464057,,0.6152944854016863
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.3492013902747454,
AH2018_TMTMS3_Pool,0.47596129130765646,,
KS2014_Intensity N4,0.47996301193926066,0.339174670847121,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,,,
CK2022_14 200-1,0.4578071568660005,,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,,,
TM2022_mock.4h.A,0.4920945548524711,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,0.48458893441518697,,
AST2020_anti-CD3+PDL2.2,,,
PG2020_Intensity Mock_10h_A,0.48936332901661705,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,,,0.6086814217352267
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,0.47201426805305774,,
GF2025_P1_Adh,0.49351917505557075,,
GF2025_P1_Sph,0.4906180754315129,,
EJN2021_5_Ex_Basal,,,0.6148354252733068
HS2024_7_I_T3,0.51458931105274,,0.6321007555599863
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.47022773067104495,,
CF2017_EOC 1,,,
CK2022_3 200-1,0.4797335329620109,,
AH2018_LFQ_IT_3_C,0.48566621028291773,,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,0.48546865143130497,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,0.5084937386070666,,0.6335057371133996
HS2024_5_B_T1,0.44926608329117007,,0.5939468833737204
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,0.4716617495458711,,
RB2022_6_PreStrength,,,
CK2022_2 40-1,0.48573172655980085,,
RB2022_1_PostSprint,,,
CK2022_4 200-1,0.4781764720291038,,
JW2021_Before_2,,,
TM2022_S2.12h.A,0.49159677889374837,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,0.48740652869614737,,
AR2021_ALG 1 μM,0.4853821422004727,,0.6225385100214587
HS2024_4_B_T1,0.48083015549032665,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,,,0.614080881008966
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,0.49000333576010413,,
CR2017_Ratio Replicate 3.2,0.5044267955516266,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,0.49370721399952433,,
CK2022_9 16-1,0.4605630445498218,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,0.4544806504922389,,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,0.46584668045935335,,
CK2022_16 16-1,0.4719470781931572,,
FS2019_db/db3,,,
CK2022_15 40-1,0.4792399894775922,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.45242628557786985,,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,,,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,0.4875403964887121,,
HS2024_5_PD_T3,0.4873874910222514,,
AH2018_TMTMS3_3_X,0.4696823821279944,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,,,
AH2018_LFQ_M_1_N,0.4936762503787841,,
KBE2022_Log2_Ex_27_U,,,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),0.4854919527142724,,0.5931426789766687
AH2018_SILAC_M_1_N,0.5005011499873964,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,,,
YA2020_Reporter_intensity_Normal_No.4,0.48525451110841317,,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,0.4829313858839117,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,0.4589610810680221,,
RN2012_L13,0.4815250857827836,,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,,,
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,0.4684601546638866,,0.6079834978064764
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,0.5427253235645901,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,0.4894403166542405,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,0.4784113899809603,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,,,
HH2022_Reporter intensity 6,0.4852320786307035,,0.614748092025903
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,0.5125669328383355,,0.6156112975361111
GF2025_P3_Adh,0.48788056963635285,,
SR2019_JIMT1_Biol_repl_2,,,
AH2018_TMTMS2_1_C,0.5137218156097922,,0.619754999111123
RM2024_Intensity D0-1___2,,,
LY2019_P4+,,,
KBE2022_Log2_Ex_19_U,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,0.4870797725902919,,
AST2020_Control,,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,0.4853970898947542,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,0.4927277179476685,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,0.49839233905690994,,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,,,
RB2022_7_RecoverySprint,,,
YA2020_Reporter_intensity_Normal_No.3,0.4834592969139865,,
HS2024_8_B_T2,0.4804936665446212,,0.6038058234534174
AH2018_LFQ_1_X,0.4904640109798854,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,0.48421459461993216,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,0.47077553107529674,,
HH2022_Reporter intensity 1,0.48581834232853477,,0.619795983644665
HH2022_Reporter intensity 2,0.48474780037967236,,0.620815977640869
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,0.4857262566325505,,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,0.49189009683429874,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,0.4795756551311128,,0.6071732881038145
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,,,
CR2017_Ratio Replicate 2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,0.4973196065320722,,
AR2021_KD 72h,0.48019589340554536,0.29936010319138023,0.6159737813600235
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,,,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,0.4789446112141666,,
KBE2022_Log2_Ex_9_U,,,
AH2018_SILAC_M_3_N,,,
KBE2022_Log2_Ex_13_T,,,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,,
PG2020_Intensity Mock_10h_C,0.4580224811848245,,
CF2017_OSE 29,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,0.5396954895570515,,
PG2020_Intensity 10h_A,0.4844436045155759,,
RN2012_L12,0.48792492267071214,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,,,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,0.4834955383613516,,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,0.49001147361391517,,
RB2022_7_RecoveryEndurance,,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,,,0.6137326645291974
TM2022_S2.12h.B,0.4928331314758272,,
RN2012_L15,0.4995972949047227,,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,0.4928385083023429,,
PG2020_Intensity 4h_A,0.4693139421533984,,
FSO2013_Ratio H/M normalized Rep2___2,0.48593369171718676,,
TM2022_mock.4h.B,0.4928418781181451,,
KBE2022_Log2_Ex_24_U,,,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,0.489537642788565,0.31250113629816045,
RB2022_1_PreSprint,,,
HS2024_4_I_N1,0.46863258646608974,,0.5923971515148645
CK2022_7 200-1,0.48083148481282856,,
CK2022_5 200-1,0.48344137373313945,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,0.5057327338817967,,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,0.487482889466866,,
AH2018_SILAC_MR_1_X,0.4819392631232436,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,,,
AH2018_SILAC_3_C,,,
EJN2021_5_Rest_Ins,,,0.6136755997299089
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,0.4818227190927984,,
CK2022_4 16-1,0.48183276528556007,,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,,,0.6127442436284828
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,0.49109790052619595,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,0.48619247447291075,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,0.4642189264224064,,
FSO2013_Ratio H/L normalized Rep3,0.5204788124129403,,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,0.492011556760727,,0.6281286878040866
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,0.4826295153283902,,
KBE2022_Log2_Ex_9_T,,,
AH2018_SILAC_IT_2_N,0.49356718177308684,,
AH2018_SILAC_IT_1_X,0.48998229905271407,,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,0.5070117005487473,,0.632767006344672
UK2020_UA_2,0.495175270602653,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,0.484011172573164,,
WZ2023_Pe_025_20min,0.4781645026458547,,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,0.48668446420354017,,
HS2024_4_I_N2,0.45192084309764,,0.6000073246269069
AH2018_TMTMS2_3_N,0.5138041019982413,,0.6161028570617029
RN2012_H06,0.5024381889055354,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,0.4498537646290779,,
WZ2023_Su_005_30min,0.4693127531441848,,
SR2019_HCC1419_Biol_repl_4,,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,0.4945982715481141,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,,,
WZ2023_Su_025_10min,0.4716170291227221,,
AH2018_LFQ_IT_4_X,,,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.4528598524582178,,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,0.4911344111032048,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,0.5069641052166862,,0.6076424246910199
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,0.4831734570658611,0.3551753047349233,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,0.47963657093042267,,
LY2019_P7+,,,
EP2017_Untreated R#1 normalized log2 ratio,0.48092797900121614,,0.5956113237620998
RN2012_L10,0.48872376860998706,,
PG2020_Intensity 4h_C,0.4681039555461795,,
EP2017_Mitotic R#3 normalized log2 ratio,0.47516376315082587,,0.634153843776699
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,,,
RB2022_8_PostStrength,,,0.6209643939471816
AH2018_SILAC_IT_2_X,0.4916505682826614,,
HS2024_4_B_T3,0.47275991718763943,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,0.4860074025206038,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,0.5086053800524024,,
KBE2022_Log2_Ex_6_U,,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.4572946185665104,,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,0.47297067506951446,,0.6330456345171263
GF2025_P9_Sph,0.48180759335388595,,
CK2022_6 200-1,0.48240794024962463,,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,0.4847152103200063,,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,,,
HS2024_4_I_T2,0.5042084802068595,,0.6308510656714559
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,0.450372593384736,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,0.5104016731684217,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,0.48148664227060095,,
EP2017_Untreated R#3 normalized log2 ratio,0.49061489397255825,,0.6234498918960055
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,0.4813534203025405,,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,,,
RB2022_7_PostEndurance,,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,0.4916709843892888,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5057546431940385,,0.6099386195529345
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,0.48566797632641584,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,0.5525338291116224,,
KBE2022_Log2_Ex_29_T,,,
HS2024_7_I_T2,0.5101711750002919,,0.6262019273586815
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,0.49483882684380054,,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,,,0.6131278324749658
FR2021_Intensity.M,,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,0.48290561994354825,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,,,
PG2020_Intensity CT_C,0.4616903735470053,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,,,
EP2017_Untreated R#3 log2 ratio,0.4908006567903985,,0.623563950224534
RB2022_2_PostStrength,,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,,,
HS2024_8_PD_T2,0.48349942197657564,,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,0.49135173022812884,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,,,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,0.4860460758517958,,
RB2022_3_PreSprint,,,
CR2017_Ratio Replicate 2.3,0.5013074805053517,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,0.4990832457272251,,
YA2020_Reporter_intensity_Normal_No.2,0.4861366967193398,,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,0.46777926372846873,,
HS2024_3_PD_T3,0.442626264980657,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,0.4901949938643033,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,,,
CK2022_2 16-1,0.4810358872401891,,
RAM2015_Log2 B,0.4791071943151947,,0.6048346368212458
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,0.4967509162228802,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,,,0.6103882657320988
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,0.498692437324499,,
UK2020_HCM_5,0.49573293009180963,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,0.49303510083338414,,
PG2020_Intensity Mock_10h_B,0.4826441418095443,,
WZ2023_Su_025_30min,0.4748488367729287,,
AH2018_LFQ_4_N,0.4854113795882804,,
CR2017_Ratio Replicate 1.2,,,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,0.4947363875108727,,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,0.48706829381856354,,0.6210867136609607
AH2018_SILAC_M_1_X,0.5004409778381137,,
RB2022_7_PreEndurance,,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,,,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,0.47958078900382867,,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,0.4676528910907339,,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,0.4809363137235008,,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,,,
KS2014_Intensity C5,0.4953851400092746,,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,0.4789836200577503,,
RB2022_3_PostStrength,,,
TM2022_S2.8h.A,0.49241582411494444,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,0.46978521057416783,,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,0.48764973352532726,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,0.4639157288156226,,
AH2018_LFQ_2_X,0.48239104649160713,,
PG2020_Intensity 2h_B,0.48320765250523495,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,,,
KS2014_Intensity E15_3,0.495280116707807,,
GF2025_P3_Sph,0.5039726722328172,,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,0.5003066695941348,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,0.5035572283546422,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.3047314155202315,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,0.491644246958831,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,,,
ZQ2022_N1,,,
LY2019_P6-,,,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,0.49696695499461907,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,0.4773916481624178,,
AH2018_LFQ_3_N,0.48662117771044205,,
RKK2015_TNF-α/IKKb,0.48338135864623494,,
SFR2015_HL_log2_ratio_std_b,0.4876843002770791,,
UK2020_UA_1,0.4954113815606494,,
KBE2022_Log2_Ex_13_U,,,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,0.48958216162320756,,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,0.46951575786417493,,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,,,
HS2024_5_PD_T2,0.4943159995855313,,
WZ2023_Su_025_20min,0.46755373797346855,,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,0.4849675027247155,,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,0.47914664274455787,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,0.4931926952743158,,
PG2020_Intensity 10h_D,0.48387728444250666,,
RB2022_8_PreEndurance,,,
HS2024_3_B_N2,0.44365938485191586,,
EJN2021_4_Ex_Ins,,,0.6124443509368896
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,,,0.6121560077889634
EP2017_Pervanadate R#3 log2 ratio,0.5041748663810125,,0.6152425410774559
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,0.4727368661964552,,
RB2022_6_PostStrength,,,
AH2018_SILAC_MR_3_C,0.48768399369854215,,
AH2018_LFQ_M_4_C,0.4876608200648134,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,0.4845076534065559,,
CK2022_6 40-1,0.4897612290531968,,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,,,
LY2019_P3-,,,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,,,0.6096258433887662
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.46521894716393364,,
HS2024_8_PD_T3,0.5074918877332323,,
EJN2021_3_Ex_Basal,,,0.612559605950489
AST2020_Control.1,,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,0.46992934726176677,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.4585540290672768,,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,0.4920669178321595,,
RB2022_1_RecoveryStrength,,,
SR2019_HCC1954_Biol_repl_4,,,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,0.4891896505384742,,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,0.5118417456374093,,0.6179920518603045
RB2022_4_PreSprint,,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,0.47927565009533096,,
HS2024_8_I_N2,0.4793552910406652,,
RB2022_3_RecoveryStrength,,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,0.5021322456217334,,
LY2019_P8+,,,
RB2022_2_RecoveryEndurance,,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.3115768859273744,
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,0.4829534098660555,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,,,
LY2019_P2-,,,
AH2018_LFQ_IT_1_X,0.499975794571485,,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,,,
WZ2023_Pe_005_20min,0.4633354789306936,,
AST2020_Control.2,,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,0.4850433910500379,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,0.47057554167270116,,0.6141506904888847
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,0.4860513445532048,,
SR2019_MCF10A_Biol_repl_4,,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,,,
HS2024_5_B_T2,0.46838694781827167,,0.6097328809190904
HS2024_6_I_T1,0.5204998224496512,,0.6365874109118272
HS2024_5_B_T3,0.5088001943749196,,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,,,
AH2018_TMTMS3_3_N,0.48007851363077175,,
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,0.4874481648584684,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,0.4771656452061134,,0.6352014857226048
KBE2022_Log2_Ex_36_T,,,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.47382581801611845,,
KS2014_Intensity C2,0.492030766701145,0.3129067691446057,
FSO2013_Ratio H/L normalized Rep1___2,0.46040196333286054,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,,,
CK2022_9 200-1,0.45567657538582773,,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,0.45789472578586937,,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,0.5380829122210036,,0.6347625585419716
RBK2021_1332T Late,,,
LY2019_P1-,,,
RKK2015_TNF-α/basal.1,0.5096851566944869,,0.643974902814213
RKK2015_TNF-α/TNF-α+SC-514,0.4950106598533523,,0.6457921723181582
CR2017_Ratio Replicate 2.5,,,
HS2024_3_I_T3,0.4650638160597603,,0.6031766693109122
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,0.4917568127937775,,
ZQ2022_C3,,,
EJN2021_3_Rest_Ins,,,0.6052983078035182
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,,,
FSO2013_Ratio H/M normalized Rep3___2,0.4851422254753447,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,0.48106785680806563,,0.5956476325479171
RKK2015_SC-514/basal,0.49395629068368774,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.4517230351118893,,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,,
HS2024_5_I_T3,0.4676097740866552,,
KS2014_Intensity N1,0.45981258999509356,0.35235017635220467,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,0.4914430067047337,,
CR2017_Ratio Replicate 1,,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,0.48642342083588647,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,0.45570702937600677,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,0.4863397936540636,,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,0.4857818608563323,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,0.49883626039085605,,
HS2024_5_B_N2,0.49758337194606644,,
HS2024_5_I_N1,0.4981432972817245,,
HS2024_6_I_N1,0.5274003506723494,,
AR2021_KD 48h,0.4910254548369091,0.3605227679937216,0.6185002551032427
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,,,
HS2024_5_I_T1,0.4900290245649469,,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,,,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.4639223666804866,,
KBE2022_Log2_Ex_29_U,,,
HS2024_7_B_T1,0.51053241321142,,
AH2018_LFQ_M_2_X,0.48699247474987784,,
AH2018_LFQ_IT_4_N,,,
CK2022_15 200-1,0.45707747347026617,,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,0.4807392274207004,,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.4680129927171275,,
RN2012_H01,0.48162740538228804,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,,,0.6120283409519313
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5064401557070274,,0.6070608214484513
HS2024_8_B_T3,0.48372472479684914,,
YA2020_Reporter_intensity_Cancer_No.3,0.4837230406216677,,
KBE2022_Log2_Ex_44_U,,,
WZ2023_Pe_010_20min,0.470649801235032,,
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,0.47875983467605443,,
RB2022_3_PreStrength,,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,0.4827882000600652,,
KS2014_Intensity C1,0.5020874810152305,,
FSO2013_Ratio H/M normalized Rep3___1,0.49675990009785026,,
AH2018_SILAC_M_3_C,,,
RKK2015_TNF-α+IKKb/TNF-α,0.4915089105959146,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,0.4860076245187123,,
AH2018_SILAC_M_2_X,0.4872497347234153,,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,,,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.47089887509739264,,
PG2020_Intensity 6h_C,0.45814462547223406,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,0.48995850593347756,,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,0.513270724836353,,0.6173134915802954
CK2022_15 16-1,0.47099100231049806,,
CK2022_3 16-1,0.4809228672329626,,
LY2019_P4-,,,
FSO2013_Ratio H/L normalized Rep3___2,0.5193042185081264,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,0.44759598110664145,,
GF2025_P8_Adh,0.4809139386050871,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,0.49263210248614314,,
CK2022_10 16-1,0.46511038719617165,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.34101994907782957,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,0.4949063967885767,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,0.47420658594964626,,0.6339269472470541
EJN2021_2_Ex_Basal,,,0.6109692843784926
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,,,
AR2021_L41 10 μM,0.4930804487183034,,0.6091194338754833
CF2017_EOC 2,,,
RB2022_6_PostEndurance,,,
AH2018_SILAC_1_N,0.5000140068058939,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,0.4961486144747682,,
RB2022_7_PreSprint,,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,0.44950053694656283,,
CK2022_6 16-1,0.48703029849597734,,
ZX2022_CB treated Replicate 1,0.48041623611286244,,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,0.4908947139835002,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,0.4846359131679853,,0.6204291883291765
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,0.5109798645941465,,0.6189196491614979
AR2021_L41 1 μM,0.47781224323993843,,0.6355416509219587
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,0.5122043872141687,,0.6187526856127318
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,0.4807711725192468,,
KS2014_Intensity C4,0.5005182788873128,,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,,,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,0.4944119890760286,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,0.5062444237492233,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,0.48693507593092644,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,0.48564366777036505,,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,,,
AH2018_SILAC_IT_3_C,0.4978254336745323,,
WZ2023_Pu_025_10min,0.46669516706016834,,
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,0.5083892536695832,,
FSO2013_Ratio M/L normalized Rep3___1,0.48908489472480077,,
SR2019_JIMT1_Biol_repl_4,,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,,,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.4708610171492477,,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,0.48800162707200045,,
KS2014_Intensity C6,,0.3075405561782905,
ZQ2022_N3,,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,0.4778418937097237,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,0.481321294909358,,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,0.4795915668553261,,
AH2018_SILAC_IT_2_C,0.4979016813460322,,
CK2022_5 40-1,0.48931821285999677,,
AH2018_LFQ_3_X,0.4885141838385605,,
UK2020_UA_3,0.4949715779038742,,
LY2019_P7-,,,
GF2025_P5_Adh,0.4903925108488191,,
RB2022_1_PostStrength,,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,0.5032271709996251,,
SR2019_HCC1954_Biol_repl_3,,,
CR2017_Ratio Replicate 2.2,0.47235393399626474,,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,0.4681483837217612,,
ZQ2022_C1,,,
CR2017_Ratio Replicate 2.1,,,
PG2020_Intensity CT_B,0.4806986752952164,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,0.48103114747700804,,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,0.4926504812252239,,
AH2018_LFQ_3_C,0.48285181560708423,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,0.4892370929464363,,
YA2020_Reporter_intensity_Cancer_No.4,0.48518502123625873,,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,0.4900029583491091,,
RB2022_2_PreEndurance,,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,0.4709889535422678,,
AST2020_anti-CD3+PDL2,,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,,,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,0.4862349794447178,,
HS2024_8_I_T1,0.4871692375204926,,0.5933422836436002
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,0.47558889894938783,,0.6402338686672243
AH2018_TMTMS2_1_X,0.5147366187037278,,0.6190466673507563
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,,,0.6129274641825133
HS2024_6_I_N2,0.4956808536482229,,
HH2022_Reporter intensity 4,,,0.6026229300315629
RBK2021_1326T Late,,,
TM2022_mock.12h.B,0.49206276493478773,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,0.49204713396250976,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,,,
HS2024_4_I_T3,0.4620326227554288,,
AH2018_SILAC_1_X,0.49994804001340265,,
PG2020_Intensity 10h_B,0.485633499636935,,
AH2018_TMTMS3_1_X,0.4803950972420464,,
CF2017_FTE 14,,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,0.48810952604390134,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,0.46889447222739533,,
SR2019_HCC1419_Biol_repl_3,,,
KBE2022_Log2_Ex_14_T,,,
EP2017_Untreated R#2 normalized log2 ratio,0.47946656002800325,,0.6070841574177063
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,,,
HS2024_5_I_N2,0.47806551892427296,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,0.5064629097328313,,0.6104943707788953
AS2011_Ratio H/L Normalized RNAi_2_1,,,
